Boston Scientific Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Boston Scientific Corp 公司

波士頓科學公司是一家全球醫療器械開發商、製造商和營銷商，其產品用於一系列介入醫學專業。其 MedSurg 部門包括內窺鏡檢查、泌尿科和神經調節。其內窺鏡業務開發和製造用於診斷和治療各種胃腸道 (GI) 和肺部疾病的設備，採用微創技術。其泌尿科業務開發和製造用於治療男性和女性各種泌尿系統疾病的設備。其神經調節業務開發和製造用於治療各種神經運動障礙和控制慢性疼痛的設備。其心血管部門包括心臟病學和外周介入。其介入心臟病學治療業務開發和製造用於診斷和治療冠狀動脈疾病和主動脈瓣疾病的技術。該公司還擁有經頸動脈血運重建 (TCAR) 平臺。

公司簡介

公司代碼BSX

公司名稱Boston Scientific Corp

上市日期May 19, 1992

成立日期1979

CEOMr. Michael F. (Mike) Mahoney

員工數量53000

證券類型Ordinary Share

年結日May 19

公司地址300 Boston Scientific Way

城市MARLBOROUGH

上市交易所NYSE Consolidated

國家United States of America

郵編01752-1234

電話15086834000

網址https://www.bostonscientific.com/en-US/Home.html

公司代碼BSX

上市日期May 19, 1992

成立日期1979

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.87M

-3.05%

Mr. Charles J. Dockendorff, CPA

Independent Director

62.90K

--

Mr. John E. Sununu

Independent Director

52.64K

--

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

36.19K

-11.77%

Ms. Ellen M. Zane

Independent Director

34.94K

--

Mr. David C. Habiger

Independent Director

3.55K

--

Mr. Yoshiaki Fujimori

Independent Director

2.90K

--

Mr. Arthur Crosswell Butcher

Executive Vice President, Group President, MedSurg and Asia Pacific

--

Mr. Edward J. Ludwig

Lead Independent Director

--

Ms. Meghan Scanlon

Senior Vice President and President - Urology

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.87M

-3.05%

Mr. Charles J. Dockendorff, CPA

Independent Director

62.90K

--

Mr. John E. Sununu

Independent Director

52.64K

--

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

36.19K

-11.77%

Ms. Ellen M. Zane

Independent Director

34.94K

--

Mr. David C. Habiger

Independent Director

3.55K

--

收入明細

單位: USD更新時間: 4月6日週日

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Endoscopy

2.69B

16.04%

Interventional Cardiology Therapies

2.65B

15.79%

Peripheral Interventions

2.41B

14.39%

Cardiac Rhythm Management

2.28B

13.61%

Urology

2.20B

13.14%

Other

4.53B

27.03%

地區USD

名稱

營收

佔比

United States

10.21B

60.97%

EMEA (Europe, Middle East and Africa)

3.23B

19.28%

Asia Pacific

2.69B

16.04%

Latin America and Canada

624.00M

3.73%

業務

地區

業務USD

名稱

營收

佔比

Endoscopy

2.69B

16.04%

Interventional Cardiology Therapies

2.65B

15.79%

Peripheral Interventions

2.41B

14.39%

Cardiac Rhythm Management

2.28B

13.61%

Urology

2.20B

13.14%

Other

4.53B

27.03%

股東統計

更新時間: 2月21日週五

持股股東

股東類型

持股股東

股東統計

佔比

The Vanguard Group, Inc.

8.94%

Fidelity Management & Research Company LLC

8.19%

BlackRock Institutional Trust Company, N.A.

5.19%

State Street Global Advisors (US)

4.32%

PRIMECAP Management Company

2.50%

Other

70.86%

持股股東

股東統計

佔比

The Vanguard Group, Inc.

8.94%

Fidelity Management & Research Company LLC

8.19%

BlackRock Institutional Trust Company, N.A.

5.19%

State Street Global Advisors (US)

4.32%

PRIMECAP Management Company

2.50%

Other

70.86%

股東類型

股東統計

佔比

Investment Advisor

43.37%

Investment Advisor/Hedge Fund

37.16%

Hedge Fund

3.29%

Pension Fund

2.97%

Research Firm

2.42%

Bank and Trust

1.65%

Sovereign Wealth Fund

1.47%

Private Equity

0.21%

Insurance Company

0.21%

Other

7.26%

機構持股

更新時間: 1月19日週日

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

2612

1.38B

93.37%

+6.11M

2024Q4

2559

1.38B

93.61%

+1.09M

2024Q3

2417

1.37B

92.76%

-24.32M

2024Q2

2341

1.37B

93.29%

-18.17M

2024Q1

2227

1.37B

93.23%

-40.14M

2023Q4

2171

1.39B

94.95%

-25.34M

2023Q3

2110

1.39B

95.17%

-6.29M

2023Q2

2081

1.38B

95.67%

-15.63M

2023Q1

2012

1.36B

94.85%

-23.81M

2022Q4

1993

1.36B

94.66%

-54.91M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

132.25M

8.94%

+1.62M

+1.24%

Dec 31, 2024

Fidelity Management & Research Company LLC

121.20M

8.19%

-2.05M

-1.66%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

76.72M

5.19%

+7.50M

+10.84%

Dec 31, 2024

State Street Global Advisors (US)

63.96M

4.32%

+1.12M

+1.78%

Dec 31, 2024

PRIMECAP Management Company

36.93M

2.5%

-896.83K

-2.37%

Dec 31, 2024

Wellington Management Company, LLP

36.17M

2.45%

+3.34M

+10.19%

Dec 31, 2024

Geode Capital Management, L.L.C.

30.63M

2.07%

+1.04M

+3.52%

Dec 31, 2024

Capital World Investors

27.90M

1.89%

+6.22M

+28.67%

Dec 31, 2024

The Bollard Group, LLC

20.73M

1.4%

-510.32K

-2.40%

Dec 31, 2024

BlackRock Investment Management (UK) Ltd.

20.37M

1.38%

+757.90K

+3.86%

Dec 31, 2024

持股ETF

更新時間: 4月6日週日

機構名稱

佔比

iShares U.S. Medical Devices ETF

10.77%

Goldman Sachs Future Health Care Equity ETF

8.56%

iShares Health Innovation Active ETF

5.12%

NYLI Healthy Hearts ETF

4.83%

JPMorgan Healthcare Leaders ETF

4.25%

Global X Aging Population ETF

3.98%

Hennessy Stance ESG ETF

3.4%

FT Raymond James Multicap Growth Equity ETF

2.84%

Tema Cardiovascular and Metabolic ETF

2.83%

iShares US Thematic Rotation Active ETF

2.82%

iShares U.S. Medical Devices ETF

佔比10.77%

Goldman Sachs Future Health Care Equity ETF

佔比8.56%

iShares Health Innovation Active ETF

佔比5.12%

NYLI Healthy Hearts ETF

佔比4.83%

JPMorgan Healthcare Leaders ETF

佔比4.25%

Global X Aging Population ETF

佔比3.98%

Hennessy Stance ESG ETF

佔比3.4%

FT Raymond James Multicap Growth Equity ETF

佔比2.84%

Tema Cardiovascular and Metabolic ETF

佔比2.83%

iShares US Thematic Rotation Active ETF

佔比2.82%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Boston Scientific Corp

102.840USD

Boston Scientific Corp

102.840

概覽

公司